ArticleRisk management and healthcare policy2026
Construction and Validation of a Nomogram Prediction Model for Recurrent Lumbar Disc Herniation After Percutaneous Endoscopic Lumbar Discectomy.
Article in Risk management and healthcare policy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To identify risk factors for recurrent lumbar disc herniation (rLDH) after percutaneous endoscopic lumbar discectomy (PELD) and to develop and internally validate a nomogram. Methods: This retrospective, single-center study included 607 patients who underwent PELD between January 2018 and December 2023. Thirty candidate predictors were collected. Predictor selection was performed using least absolute shrinkage and selection operator (LASSO) regression, followed by multivariable logistic regression. A nomogram was constructed in accordance with the Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD) recommendations. Discrimination was assessed using the area under the receiver operating characteristic curve (AUC); for a binary outcome, the concordance index (C-index) is numerically equivalent to the AUC and was therefore reported for internal validation. Calibration was evaluated using the Hosmer-Lemeshow test and calibration curves. Internal validation was conducted using bootstrap resampling (1,000 iterations) and 10-fold cross-validation. Decision curve analysis (DCA) was applied to evaluate clinical utility. Results: During follow-up, 70 of 607 patients (11.5%) developed rLDH. Seven independent predictors were identified: postoperative activity, body mass index (BMI), smoking, ligamentum flavum (LF) thickness, sagittal range of motion (sROM), Modic change, and Pfirrmann grade. The nomogram achieved an AUC of 0.793 (95% CI: 0.736-0.850) and good calibration (Hosmer-Lemeshow P = 0.668). Internal validation showed a C-index of 0.763 (95% CI: 0.682-0.844) in bootstrap resampling and 0.775 in 10-fold cross-validation. The calibration curve showed close alignment with the ideal curve. DCA demonstrated favorable clinical utility of the model. Conclusion: This internally validated nomogram integrates clinical and imaging predictors to provide individualized rLDH risk prediction after PELD. It may assist in identifying patients at higher risk of recurrence who could benefit from closer postoperative surveillance and individualized decision-making. External validation is warranted before broad clinical implementation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.